Claire Mazumdar SEC EDGAR Filings (CIK 0002034671)

SEC EDGAR filings, ownership reports, and insider transactions for Claire Mazumdar.

Business address
Bicara Therapeutics Inc., 116 Huntington Avenue, Suite 703, Boston, MA, 02116
Top holdings (ownership)
BCAX
Get insider transactions for this reporting owner
Claire Mazumdar has filed 12 SEC EDGAR filings since 12 Sep 2024

Latest Filings

Recent SEC filings for Claire Mazumdar including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 04 Feb 2026 02 Feb 2026 001-42271
4 Open 4 document View SEC filing for 4 FORM 4 18 Dec 2025 16 Dec 2025 001-42271
4 Open 4 document View SEC filing for 4 FORM 4 25 Nov 2025 24 Nov 2025 001-42271
144 Open 144 document View SEC filing for 144 24 Nov 2025
4 Open 4 document View SEC filing for 4 FORM 4 20 Oct 2025 16 Oct 2025 001-42271
144 Open 144 document View SEC filing for 144 16 Oct 2025
4 Open 4 document View SEC filing for 4 FORM 4 15 Oct 2025 13 Oct 2025 001-42271
144 Open 144 document View SEC filing for 144 15 Oct 2025
144 Open 144 document View SEC filing for 144 14 Oct 2025
4 Open 4 document View SEC filing for 4 4 11 Jun 2025 09 Jun 2025 001-39385
3 Open 3 document View SEC filing for 3 3 11 Jun 2025 09 Jun 2025 001-39385
3 Open 3 document View SEC filing for 3 3 12 Sep 2024 12 Sep 2024 001-42271

About this filer

Claire Mazumdar files with the SEC under CIK 0002034671. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages